Who invests in alternative protein companies?

This blog post has been written by the person who has mapped the alternative protein market in a clean and beautiful presentation

The alternative protein investment landscape has evolved dramatically, with $1.1 billion raised in 2024 despite a 27% decline from the previous year.

Fermentation technologies emerged as the standout winner, capturing $651 million and showing 43% growth, while precision fermentation companies alone raised $130 million in Europe—triple the previous year's amount. Understanding who backs these companies is crucial for entrepreneurs seeking funding and investors looking for opportunities in this $28.6 billion global market.

And if you need to understand this market in 30 minutes with the latest information, you can download our quick market pitch.

Which venture capital firms are actively investing in alternative protein companies and what startups have they backed recently?

Specialized venture capital firms dominate the alternative protein investment landscape, with several standout players writing significant checks across different funding stages.

EQT Ventures leads the pack with Series A and B investments ranging from $50-70 million, notably backing Formo's $61 million Series B for koji-based cream cheese technology. CPT Capital, a London-based fund, operates across the investment spectrum with deals from $2.5-50 million, having invested in Better Dairy, Hoxton Farms, and THIS. Better Food Ventures specializes in early-stage investments, writing checks from $250,000 to $10 million while focusing on digitization across the food value chain.

Lowercarbon Capital has emerged as a major climate-focused investor, actively investing across all alternative protein categories with a particular emphasis on technologies that can demonstrate clear environmental benefits. Agronomics maintains a specialized focus on cellular agriculture and cultivated meat technologies, positioning itself as a go-to investor for the most capital-intensive protein innovations. Synthesis Capital has built a reputation for backing founders in cultivated meat and fermentation, with partners emphasizing the importance of founder resilience in this challenging market environment.

Corporate venture arms have also become major players, with Grosvenor Food & AgTech leading Meati's $100 million Series C1—the largest alternative protein round of 2024. Breakthrough Energy Ventures, backed by Bill Gates, participated in Prolific Machines' $55 million Series B, demonstrating continued interest from high-profile impact investors.

Need a clear, elegant overview of a market? Browse our structured slide decks for a quick, visual deep dive.

What are the typical funding amounts and deal terms these investors offer?

Deal sizes vary significantly by technology platform, with cultivated meat companies commanding the highest average investments at $96 million per round, compared to $57 million for fermentation technologies and $31 million for plant-based companies.

The disparity reflects the capital-intensive nature of different alternative protein approaches. Cultivated meat requires substantial investment in bioprocessing infrastructure, specialized equipment, and regulatory compliance, driving up funding requirements. Fermentation technologies occupy a middle ground, needing significant R&D investment but benefiting from more established manufacturing processes. Plant-based companies typically require the least capital due to their reliance on more mature food processing technologies.

Recent funding rounds demonstrate these patterns clearly. Meati Foods raised $100 million for mycelium-based meat production, Perfect Day secured $90 million for precision fermentation dairy proteins, and Infinite Roots obtained $58 million for mycelium protein development. Early-stage investments show different dynamics, with seed rounds typically ranging from $250,000 to $5 million, while Series A rounds commonly fall between $10-25 million.

Investor expectations have shifted dramatically since 2022. PeakBridge now requires $500,000+ in revenue for seed funding, reflecting a broader trend toward revenue-focused investing rather than pure technology potential. This represents a significant change from the earlier years when investors were willing to back pre-revenue companies based primarily on technological innovation and market potential.

If you want fresh and clear data on this market, you can download our latest market pitch deck here

Which regions are attracting the most alternative protein investment currently?

Europe has emerged as the unexpected leader in alternative protein investment growth, with companies raising nearly $509 million in 2024—a 23% increase from the previous year, bucking the global downward trend.

The European surge was driven primarily by precision fermentation companies, which raised $130 million (triple the previous year), and plant-based investments increasing 37% to $181 million. Europe now accounts for 47% of global deals in Q1-Q3 2024, compared to North America's 24% share. This represents a dramatic shift from historical patterns where North American companies typically dominated funding volumes.

Regional sales performance supports these investment patterns. Europe leads globally with $9.7 billion in plant-based sales, followed by Asia-Pacific at $8.9 billion and North America at $7.3 billion. The European market's maturity and consumer acceptance create a more stable foundation for investor confidence, particularly as macroeconomic headwinds affect riskier markets.

Asia-Pacific presents compelling growth potential despite lower visibility in funding data. The region showed remarkable growth in 2022 with total alternative protein investments increasing 43% to $562 million. Plant-based investments rose 30% to $372 million, fermentation investments jumped 67% to $95 million, and cultivated investments nearly doubled with 96% growth to $95 million. This momentum positions APAC as a key region to watch for future investment flows.

Which major corporations are backing or acquiring alternative protein startups?

Four corporate giants—ADM, Tyson, Cargill, and Danone—account for 18% of all recorded alternative protein transactions, demonstrating how established food companies are actively reshaping the industry through strategic investments.

What are the most notable startup success stories and who were their early backers?

Perfect Day stands as the most successful alternative protein startup to date, having raised over $840 million while pioneering animal-free dairy proteins through precision fermentation technology.

The company's journey began with early backing from specialized investors who recognized the potential of precision fermentation before it became mainstream. Their success in achieving regulatory approval and commercial partnerships with major food companies like Unilever demonstrates the pathway from innovative technology to market validation. Perfect Day's $90 million Series E in 2024 shows continued investor confidence even in a challenging funding environment.

Formo represents another European success story, achieving $117 million in total funding for koji-based dairy alternatives. Their $61 million Series B, one of 2024's largest alternative protein rounds, was led by EQT Ventures and demonstrates strong investor appetite for fermentation technologies that can achieve cost parity with conventional dairy products. The company's focus on traditional fermentation processes appeals to investors seeking technologies with clearer regulatory pathways.

Regulatory approval milestones have created additional success stories. GOOD Meat achieved the historic first approval for cultivated meat in Singapore in 2020, followed by FDA and USDA approval in the United States in 2023. UPSIDE Foods also secured US regulatory approval, while Meatly received the first European approval for cultivated pet food in the UK in 2024. Vow launched cultivated quail in Hong Kong, making it the third market globally to embrace cultivated meat products.

Wondering who's shaping this fast-moving industry? Our slides map out the top players and challengers in seconds.

Which technologies and scientific breakthroughs are currently attracting the most investor interest?

Precision fermentation has emerged as the clear technology leader, attracting $651 million globally in 2024 and demonstrating 43% growth while other categories declined.

The technology's appeal stems from its ability to produce animal proteins without animals, using engineered microorganisms to create identical proteins found in conventional dairy, eggs, and meat. European precision fermentation companies alone raised $130 million in 2024—triple the previous year's amount—indicating accelerating investor confidence in the approach. Companies like Solar Foods are pushing boundaries further with gas fermentation, converting CO₂ directly into edible protein using renewable energy.

AI-driven optimization represents the next frontier attracting significant investment. Machine learning applications for microbial selection and fermentation optimization promise to dramatically reduce production costs and improve product quality. Predictive analytics help companies optimize fermentation conditions, reducing trial-and-error experimentation that has historically slowed product development. Advanced bioprocessing innovations, including continuous manufacturing systems, offer potential cost reductions that could achieve price parity with conventional proteins.

Breakthrough innovations in bioprocessing have captured investor attention, particularly continuous bioprocessing systems that enable daily biomass harvests rather than traditional batch processing. Hebrew University research demonstrated cost-effective cultivated meat production using tangential flow filtration, while animal component-free culture media priced at $0.63 per liter addresses one of cultivated meat's major cost challenges. These technological advances directly address the industry's primary barriers to commercial success.

If you want to build or invest on this market, you can download our latest market pitch deck here

Which government and institutional investors are most actively supporting alternative proteins?

Government funding reached approximately $510 million in new commitments globally in 2024, with total cumulative support approaching $2.1 billion since tracking began, while annual disbursements jumped to $560 million from $348 million in 2023.

The United Kingdom leads government investment with the National Alternative Protein Innovation Centre (NAPIC) receiving £15 million plus £23 million from partners, part of £75 million in cumulative UK spending on sustainable proteins. The European Union supports alternative protein development through Horizon Europe funding initiatives and the €16 million Biotech Open Platform investment connecting Danone and Michelin for precision fermentation research.

The United States provides support through SBIR/STTR programs, which awarded $5.9 million to alternative protein startups as of August 2024, with congressional funding supporting operations across 13 states for crop and technology development. Canada has committed $112 million through Protein Industries Canada, while Denmark leads European funding with €96 million and a national action plan specifically focused on plant-based foods.

Specialized research grant programs offer targeted support for innovation. The Good Food Institute's Research Grants program makes up to $3.5 million available in 2025, with individual projects receiving up to $250,000 for alternative protein research. The UK's Alternative Protein Innovation Collaborative provides £4 million for academic-industry collaborations, creating bridges between research institutions and commercial development. Japan has allocated $19.6 million in grants to IntegriCulture and UMAMI UNITED, demonstrating Asian government commitment to the sector.

How much total capital was raised in alternative proteins during 2024 and early 2025?

Alternative protein companies raised $1.1 billion globally in 2024, representing a 27% decrease from 2023 levels, while Q1 2025 saw $235 million raised with fermentation technologies capturing $146 million of that total.

The 2024 funding distribution reveals clear technology preferences among investors. Fermentation technologies dominated with $651 million raised globally, showing 43% growth and bucking the overall downward trend. This contrasts sharply with other categories that experienced significant declines, indicating investor preference for technologies with clearer paths to commercial viability and regulatory approval.

Regional funding patterns show Europe outperforming other markets with nearly $509 million raised, achieving 23% growth while other regions declined. European precision fermentation companies alone captured $130 million—triple the previous year—while plant-based investments increased 37% to $181 million. This regional strength demonstrates how supportive regulatory environments and consumer acceptance can sustain investment during challenging macroeconomic periods.

The five largest funding rounds of 2024 totaled $364 million, with Meati Foods' $100 million Series C1 leading the pack, followed by Perfect Day's $90 million Series E, Formo's $61 million Series B, Infinite Roots' $58 million Series B, and Prolific Machines' $55 million Series B1. These deals represent 33% of total 2024 funding, indicating concentration among a few well-capitalized companies while smaller startups face increasing funding challenges.

How has investment volume evolved over the past two years and what trends are emerging?

Investment patterns have shifted dramatically from peak 2021-2022 levels, with funding declining from over $5 billion annually to $1.1 billion in 2024, while deal quality has improved as investors focus on companies with proven traction and clear paths to profitability.

The funding correction reflects broader venture capital trends but also industry-specific challenges. High interest rates have reduced overall venture capital availability, while consumer price sensitivity has limited adoption of premium-priced alternative protein products. Many plant-based companies experienced declining sales, with the US market falling 4% in 2024, forcing investors to become more selective about market fundamentals rather than just technological innovation.

Valuation multiples have compressed significantly as investors demand stronger unit economics and clearer timelines to profitability. PeakBridge's requirement for $500,000+ revenue for seed funding exemplifies this shift toward revenue-focused investing. M&A activity has accelerated as weaker companies exit the market, creating consolidation opportunities for stronger players with better access to capital.

Technology preferences have crystallized around fermentation approaches, which raised $651 million globally while showing 43% growth. This concentration reflects investor confidence in fermentation's regulatory clarity, scalability potential, and shorter timeline to market compared to cultivated meat technologies. The trend suggests future funding will increasingly favor technologies with demonstrated commercial viability over purely innovative approaches.

Looking for the latest market trends? We break them down in sharp, digestible presentations you can skim or share.

If you need to-the-point data on this market, you can download our latest market pitch deck here

Which startups have completed recent Series A, B, or C rounds and what are their growth strategies?

Recent significant funding rounds demonstrate clear patterns around fermentation technologies and companies with established revenue streams, reflecting investor preference for proven business models over pure innovation plays.

Formo's $61 million Series B represents one of Europe's largest alternative protein rounds, focusing on koji-based cream cheese production with plans to achieve cost parity with conventional dairy products. The company's growth strategy emphasizes B2B partnerships with food manufacturers rather than direct consumer sales, reducing marketing costs and accelerating market penetration. Their approach leverages traditional fermentation processes that face fewer regulatory hurdles than novel protein production methods.

Infinite Roots raised $58 million in Series B funding for mycelium protein development, targeting both food applications and sustainable packaging materials. Their dual-use strategy creates multiple revenue streams while spreading risk across different market segments. The company's production facilities in Germany position them to serve the European market where consumer acceptance of alternative proteins runs highest globally.

Prolific Machines secured $55 million in Series B1 funding for cultivated meat infrastructure, focusing on the tools and equipment needed by other companies rather than developing end products directly. This "picks and shovels" approach appeals to investors seeking exposure to cultivated meat growth without the regulatory and consumer acceptance risks facing product companies. Their customer base includes multiple cultivated meat startups, providing diversified revenue sources.

Several smaller but notable rounds include companies pursuing niche strategies. Rebellyous Foods developed automated plant-based meat processing equipment achieving 2,500-5,000 lb./hr production capacity, targeting food service and manufacturing efficiency rather than consumer products. This B2B focus reduces marketing costs while addressing real operational needs in the food industry.

What are the expert projections for funding and investor activity in 2026?

Industry experts predict a cautious recovery in 2026, with Lever VC's managing partner Nick Cooney noting that capital is slowly returning to the space as macroeconomic conditions improve and successful companies demonstrate clear paths to profitability.

Market size projections suggest substantial growth potential that should attract increased investment. The global alternative protein market is expected to reach $25.2 billion by 2029 with a 9.9% CAGR, while the European plant-based market alone is projected to hit $20.5 billion by 2029 with 8.1% annual growth. More aggressive projections from Future Market Insights suggest the market could reach $589.9 billion by 2035 with 18.5% CAGR, though this includes broader definitions of alternative proteins.

Technology convergence is expected to drive increased investor interest, particularly in hybrid products combining cultivated cells with plant-based ingredients, AI optimization for ingredient formulation and process control, and precision fermentation scaling to achieve industrial-scale biomanufacturing. These convergence opportunities create new investment categories that could attract both traditional food investors and technology-focused venture capital.

Consolidation through M&A activity is expected to accelerate as weaker companies exit and stronger players acquire complementary technologies or customer bases. This consolidation could provide exit opportunities for early investors while creating larger, more stable companies capable of competing with conventional protein producers. Government support is likely to continue, with several countries planning increased investment in sustainable protein research and infrastructure development.

Planning your next move in this new space? Start with a clean visual breakdown of market size, models, and momentum.

Where can investors and entrepreneurs find reliable databases, reports, and networking opportunities?

The Good Food Institute provides the most comprehensive resources for alternative protein market intelligence, including their Alternative Protein Company Database with detailed company profiles, funding status, and market data, plus an Investor Directory connecting accredited investors with startups seeking capital.

• Essential Databases: GFI's Alternative Protein Company Database offers the most complete directory of companies worldwide, while their Research Funding Database curates grant opportunities specifically for alternative protein research. The APAC Alternative Protein Ecosystem Database provides regional supplier and facility mapping for Asian markets.
• Key Industry Events: Future Food-Tech Alternative Proteins Summit (Chicago, June 2-3, 2025) brings together investors and entrepreneurs, while Future of Protein Production Amsterdam (October 29-30, 2025) serves as Europe's premier networking event with 1,000+ attendees. NAPIC Conference (Sheffield, September 15-16, 2025) offers the inaugural UK national conference focusing on commercialization.
• Specialized Platforms: Dealroom.co tracks VC funds focusing on alternative protein investments, while Net Zero Insights provides emissions and investment data analyzed by GFI. The Alternative Protein Project connects university chapters and educational resources for emerging professionals.
• Accelerator Programs: Space-F operates as Thailand's first FoodTech incubator, while Bezos Earth Fund Centers provide three global hubs for sustainable protein research. ProVeg International runs university student competitions that identify emerging talent and innovations.

Conclusion

Sources

1. Food Business News - Investment Lags Interest in Alternative Proteins
2. Green Queen - GFI State of Industry Report 2024
3. Good Food Institute - Investment Resources
4. Seedtable - Investors in Alternative Proteins
5. Visible VC - FoodTech Venture Capital
6. Institute of Food Technologists - Alternative Proteins Digital Exclusive
7. Food Navigator USA - Venture Capital Return to Alt Protein
8. Green Queen - Alt Protein Future Food Funding Rounds 2024
9. Oxford Smith School - Corporate Venturing in Alternative Proteins
10. GFI Europe - Alternative Protein Investment Figures
11. Food & Beverage - European Alternative Protein Investment Report
12. GFI - State of Global Policy on Alternative Proteins
13. GFI APAC - APAC Alt Protein Investments 2022
14. GFI Europe - UK Government NAPIC Investment
15. GFI - Alternative Proteins State of Global Policy
16. Future Market Insights - Alternative Protein Market Report
17. GFI - Alternative Protein Company Database
18. Rethink Events - Future Food Tech Alternative Proteins 2025
19. Future of Protein Production Amsterdam
20. University of Sheffield - NAPIC Conference